Northern Trust’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$440K Sell
152,282
-390
-0.3% -$832 ﹤0.01% 3660
2025
Q4
$246K Buy
152,672
+1,531
+1% +$2.41K ﹤0.01% 3907
2025
Q3
$254K Sell
151,141
-1,772
-1% -$2.87K ﹤0.01% 3896
2025
Q2
$185K Sell
152,913
-368,356
-71% -$534K ﹤0.01% 3960
2025
Q1
$662K Sell
521,269
-19,701
-4% -$51.5K ﹤0.01% 3456
2024
Q4
$1.76M Sell
540,970
-161,850
-23% -$583K ﹤0.01% 3100
2024
Q3
$2.31M Sell
702,820
-9,348
-1% -$36.4K ﹤0.01% 2915
2024
Q2
$3.03M Sell
712,168
-20,246
-3% -$197K ﹤0.01% 2674
2024
Q1
$10.8M Sell
732,414
-42,065
-5% -$636K ﹤0.01% 1989
2023
Q4
$7.45M Buy
774,479
+4,309
+0.6% +$29.8K ﹤0.01% 2260
2023
Q3
$3.59M Buy
770,170
+19,781
+3% +$98.5K ﹤0.01% 2632
2023
Q2
$4.01M Buy
750,389
+45,571
+6% +$281K ﹤0.01% 2619
2023
Q1
$5.05M Sell
704,818
-18,593
-3% -$112K ﹤0.01% 2469
2022
Q4
$4.85M Sell
723,411
-42,505
-6% -$233K ﹤0.01% 2507
2022
Q3
$2.65M Buy
765,916
+193,503
+34% +$740K ﹤0.01% 2858
2022
Q2
$1.69M Sell
572,413
-20,097
-3% -$106K ﹤0.01% 3149
2022
Q1
$5.22M Sell
592,510
-30,042
-5% -$332K ﹤0.01% 2566
2021
Q4
$9.99M Sell
622,552
-12,799
-2% -$241K ﹤0.01% 2225
2021
Q3
$13.3M Sell
635,351
-14,285
-2% -$344K ﹤0.01% 2081
2021
Q2
$17.4M Buy
649,636
+39,223
+6% +$1.15M ﹤0.01% 1985
2021
Q1
$19.4M Sell
610,413
-41,724
-6% -$1.01M ﹤0.01% 1844
2020
Q4
$14.9M Sell
652,137
-704
-0.1% -$16.2K ﹤0.01% 1993
2020
Q3
$16.4M Buy
652,841
+19,364
+3% +$529K ﹤0.01% 1771
2020
Q2
$17.7M Buy
633,477
+12,371
+2% +$215K ﹤0.01% 1720
2020
Q1
$3.61M Buy
621,106
+10,399
+2% +$94.4K ﹤0.01% 2487
2019
Q4
$6.64M Sell
610,707
-33,113
-5% -$328K ﹤0.01% 2417
2019
Q3
$8.21M Buy
643,820
+87,317
+16% +$1.26M ﹤0.01% 2266
2019
Q2
$9.44M Buy
556,503
+6,089
+1% +$105K ﹤0.01% 2187
2019
Q1
$9.9M Buy
550,414
+25,914
+5% +$448K ﹤0.01% 2150
2018
Q4
$6.66M Buy
524,500
+1,644
+0.3% +$27.6K ﹤0.01% 2327
2018
Q3
$11.2M Buy
522,856
+9,100
+2% +$194K ﹤0.01% 2193
2018
Q2
$10.6M Buy
513,756
+80,233
+19% +$1.81M ﹤0.01% 2231
2018
Q1
$10.9M Buy
433,523
+1,300
+0.3% +$31.6K ﹤0.01% 2116
2017
Q4
$8.21M Buy
432,223
+1,860
+0.4% +$34.7K ﹤0.01% 2318
2017
Q3
$7.95M Sell
430,363
-2,515
-0.6% -$43.6K ﹤0.01% 2343
2017
Q2
$7.58M Buy
432,878
+33,914
+9% +$647K ﹤0.01% 2344
2017
Q1
$7.42M Buy
398,964
+16,171
+4% +$312K ﹤0.01% 2324
2016
Q4
$7.83M Buy
382,793
+3,257
+0.9% +$82K ﹤0.01% 2263
2016
Q3
$11.4M Buy
379,536
+5,264
+1% +$157K ﹤0.01% 1976
2016
Q2
$10.1M Buy
374,272
+10,602
+3% +$239K ﹤0.01% 2018
2016
Q1
$6.82M Buy
363,670
+7,833
+2% +$149K ﹤0.01% 2222
2015
Q4
$11M Buy
355,837
+9,094
+3% +$276K ﹤0.01% 1949
2015
Q3
$7.43M Buy
346,743
+104,758
+43% +$3.29M ﹤0.01% 2192
2015
Q2
$9.19M Buy
241,985
+20,693
+9% +$680K ﹤0.01% 2112
2015
Q1
$6.94M Buy
221,292
+24,944
+13% +$845K ﹤0.01% 2298
2014
Q4
$6.89M Sell
196,348
-7,603
-4% -$190K ﹤0.01% 2289
2014
Q3
$4.26M Buy
203,951
+113,636
+126% +$2.35M ﹤0.01% 2611
2014
Q2
$1.96M Buy
90,315
+12,731
+16% +$268K ﹤0.01% 3101
2014
Q1
$2.16M Sell
77,584
-1,632
-2% -$57.6K ﹤0.01% 3089
2013
Q4
$2.17M Buy
+79,216
New +$2.07M ﹤0.01% 3102

Other funds holding MGNX

Northern Trust's MGNX Position: Q1 2026 in Review

Northern Trust reduced its MacroGenics (MGNX) stake by 0.26% in Q1 2026, selling an estimated $832 and leaving 152,282 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #3660.

Northern Trust first reported a position in MGNX in Q4 2013 and has held it in 50 quarters since. The position peaked at $19.4M in Q1 2021. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Northern Trust held 152,282 shares of MacroGenics worth $440K as of Q1 2026.
  • Northern Trust sold 390 MacroGenics shares in Q1 2026, an estimated $832.
  • MacroGenics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3660 holding.
  • Northern Trust first reported a position in MacroGenics in Q4 2013 and has held it in 50 quarters since.
  • Northern Trust's MacroGenics position peaked at $19.4M in Q1 2021.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.